Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $27,221 - $58,784
16,700 New
16,700 $28,000
Q2 2022

Jul 21, 2022

SELL
$2.2 - $4.2 $80,960 - $154,560
-36,800 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$2.83 - $8.69 $5,094 - $15,642
1,800 Added 5.14%
36,800 $141,000
Q4 2021

Jan 25, 2022

BUY
$8.31 - $14.92 $290,850 - $522,200
35,000 New
35,000 $185,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $489M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.